[1] Wang Q, Yang F, Miao Q, et al. The clinical phenotypes of autoimmune hepatitis: a comprehensive review[J]. J Autoimmun, 2016, 66:98-107. [2] Czaja AJ. Diagnosis and management of autoimmune hepatitis: current status and future directions[J]. Gut Liver, 2016, 10(2):177-203. [3] Charrow A, Imadojemu S, Stephen S, et al. Cutaneous manifestations of IgG4-related disease (RD): a systematic review[J]. J Am Acad Dermatol, 2016, 75(1):197-202. [4] Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease[J]. Ann Rheum Dis, 2015, 74(1):14-18. [5] McFarlane IG. Pathogenesis of autoimmune hepatitis[J]. Biomed Pharmacother, 1999, 53(5-6):255-263. [6] Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol, 1999, 31(5):929-938. [7] Nakanuma Y, Ishizu Y, Zen Y, et al. Histopathology of IgG4-related autoimmune hepatitis and IgG4-related hepatopathy in IgG4-related disease[J]. Semin Liver Dis, 2016, 36(3):229-241. [8] Liberal R, de Boer YS, Andrade RJ, et al. Expert clinical management of autoimmune hepatitis in the real world[J]. Aliment Pharmacol Ther, 2017, 45(5):723-732. [9] Balitzer D, Shafizadeh N, Peters MG, et al. Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria[J]. Mod Pathol, 2017, 30(5):773-783. [10] Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease[J]. Lancet, 2015, 385(9976):1460-1471. [11] Andrew NH, Sladden N, Kearney DJ, et al. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD[J]. Br J Ophthalmol, 2015, 99(3):376-381. [12] Ota M, Umemura T, Kawa S. Immunogenetics of IgG4-related AIP//Okazaki K. IgG4-related disease[M]. Cham: Springer, 2017: 35-44. [13] Perricone G. IgG4-hepatopathy and IgG4-associated autoimmune hepatitis[J]. Aliment Pharmacol Ther, 2015, 41:326-327. [14] Jiménez-Rivera C, Ling SC, Ahmed N, et al. Incidence and characteristics of autoimmune hepatitis[J]. Pediatrics, 2015, 136(5):e1237-e1248. [15] Aizawa Y, Hokari A. Autoimmune hepatitis: current challenges and future prospects[J]. Clin Exp Gastroenterol, 2017, 10:9-18. |